Moderna Inc said the US Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunisation Practices voted to recommend the use of the company's COVID-19 vaccine on people 18 years of age and older.
The panel voted 11-0 in favour of the vaccine, the company said in a press release.
The vote result came a day after the Food and Drug Administration's authorisation for emergency use of Moderna's COVID-19 vaccine.
"ACIP recommendation is another step forward in our quest to address this devastating pandemic with a vaccine," Chief Executive Officer Stephane Bancel said in the release.
Moderna's is the second COVID-19 vaccine to receive approval in the United States after a similar vaccine from Pfizer Inc and German partner BioNTech SE got the green light for emergency use.
US distribution of Moderna's vaccine began on Saturday, with more than 3,700 sites due to start receiving and administering shots as soon as Monday.
Iran denies talks with US after Trump postpones strikes on power grid
Israeli minister calls for annexation of southern Lebanon
Kim Jong Un says North Korea’s nuclear status is irreversible, threatens South
Japan to start releasing oil from joint stockpiles by end-March, PM says
Seven overhead power lines out of service due to falling debris in Kuwait
Death toll nearly doubles to 66 in Colombian military plane crash
Ukraine's Zelenskyy says Russia preparing new massive attack
Rockets launched from Iraq’s Mosul towards US base in Syria
